arrow
L

Laura E. Schanberg

Duke Clinical Research Institute
H指数:43
被引数:6,507

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis

验证患者报告结局测量信息系统(PROMIS)儿科测量工具在慢性非细菌性骨髓炎患儿中的应用

2026-09-100
OAAI
Congruence Between Child Self-Reported and Caregiver-Proxy- Reported Health-Related Quality of Life in Children With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus

儿童自我报告与监护人代理报告在幼年特发性关节炎和系统性红斑狼疮患儿健康相关生活质量中的吻合度

2026-05-010
PRE
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry

卡纳库单抗在全身型幼年特发性关节炎患者中的长期安全性:童年关节炎和风湿病研究联盟(CARRA)登记研究的5年结果

2025-10-230
OAAI
Investigation of the performance of validated cardiovascular risk scores in a global (UK/US) cohort of young people with childhood-onset systemic lupus erythematosus

在全球 (英国/美国) 儿童期发病的系统性红斑狼疮年轻人队列中,对经过验证的心血管风险评分的性能进行调查

2024-06-131
OAAI
VALIDATION OF PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) QUESTIONNAIRES FOR CHILDREN WITH CHRONIC NONBACTERIAL OSTEOMYELITIS USING THE CHOIR DATA

验证患有慢性非细菌性骨髓炎的儿童患者报告结局测量信息系统(PROMIS)问卷,采用CHOIR数据。

2024-06-010
PRE
Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

使用一种新的脂质代谢组学特征,可以预测患有青少年系统性红斑狼疮的年轻人的APPLE试验中的动脉粥样硬化进展

2023-12-198
OA
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design

多关节病程幼年特发性关节炎的治疗进展: 外推,剂量选择和临床试验设计

2023-08-031
OAAI
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

会议报告: ALPHA项目: 关于狼疮临床试验结果指标和患者观点的利益相关者会议

2023-02-141
OAAI